191 related articles for article (PubMed ID: 33084992)
21. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
[TBL] [Abstract][Full Text] [Related]
22. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
23. Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.
Lv Y; Pan Y; Dong C; Liu P; Zhang C; Xing D
Med Sci Monit; 2017 Aug; 23():3780-3788. PubMed ID: 28775246
[TBL] [Abstract][Full Text] [Related]
24. Inflammation-based prognostic scores in geriatric patients with rectal cancer.
Manoglu B; Sokmen S; Bisgin T; Semiz HS; Görken IB; Ellidokuz H
Tech Coloproctol; 2023 May; 27(5):397-405. PubMed ID: 36197565
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Inflammation Biomarkers in Penile Squamous Cell Carcinoma Patients Without Distant Metastasis.
Xue T; Li ZS; Wu C; Li YH; Liu ZW; Qin ZK; Yao K; Zhou FJ; Han H
Clin Genitourin Cancer; 2023 Oct; 21(5):e334-e342.e1. PubMed ID: 37225533
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma.
Liang Y; Xiao W; Guan YX; Wang W; Chen HY; Fang C; Zhang X; Zhou ZW
Oncotarget; 2017 Nov; 8(58):98135-98147. PubMed ID: 29228679
[TBL] [Abstract][Full Text] [Related]
30. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
[TBL] [Abstract][Full Text] [Related]
31. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory Risk Factors for Early Recurrence of Non-Small Cell Lung Cancer Within One Year Following Curative Resection.
Kobayashi S; Karube Y; Matsumura Y; Nishihira M; Inoue T; Araki O; Maeda S; Chida M
World J Surg; 2020 Oct; 44(10):3510-3521. PubMed ID: 32462215
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of pretreatment Glasgow prognostic score in stage IIIB geriatric non-small cell lung cancer patients undergoing radical chemoradiotherapy.
Topkan E; Bolukbasi Y; Ozdemir Y; Besen AA; Mertsoylu H; Selek U
J Geriatr Oncol; 2019 Jul; 10(4):567-572. PubMed ID: 31178158
[TBL] [Abstract][Full Text] [Related]
34. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
35. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of C-reactive protein and albumin in patients undergoing resection of colorectal liver metastases. A retrospective cohort study.
Frühling P; Hellberg K; Ejder P; Strömberg C; Urdzik J; Isaksson B
HPB (Oxford); 2021 Jun; 23(6):970-978. PubMed ID: 33214053
[TBL] [Abstract][Full Text] [Related]
37. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
[No Abstract] [Full Text] [Related]
38. Preoperative C-Reactive Protein/Albumin Ratio as a Predictive Factor for Gallbladder Carcinoma.
Utsumi M; Aoki H; Nagahisa S; Nishimura S; Une Y; Kimura Y; Watanabe M; Taniguchi F; Arata T; Katsuda K; Tanakaya K
In Vivo; 2020; 34(4):1901-1908. PubMed ID: 32606161
[TBL] [Abstract][Full Text] [Related]
39. The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma.
Yu X; Wen Y; Lin Y; Zhang X; Chen Y; Wang W; Wang G; Zhang L
J Cancer; 2018; 9(5):807-815. PubMed ID: 29581759
[TBL] [Abstract][Full Text] [Related]
40. ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
Matsubara T; Okamoto T
Ann Surg Oncol; 2021 Jun; 28(6):3055-3056. PubMed ID: 33095364
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
